LA JOLLA PHARMACEUTICAL CO 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 3, 2007
Insider Transaction Report
Form 4
JENN PAUL
VP of Product Development
Transactions
- Sale
Common Stock
2006-12-29$3.11/sh−5,000$15,541→ 6,804 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated as of July 27, 2006.